Patent 5856298 Issued on January 5, 1999. Estimated Expiration Date: January 5, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Erythropoietin isoforms having a specific number of sialic acids per erythropoietin molecule are disclosed. Also disclosed are mixtures of such isoforms, pharmaceutical compositions containing such isoforms or mixtures thereof and methods of obtaining the erythropoietin isoforms.
Other References
Fuhr et al., Biochemical and Biophysical Research Communications 98: 930-935, Feb. 27,1981
Viau et al., Biochemical and Biophysical Research Communications 117: 324-331, Nov. 30, 1983
Havel et al., Proc. Natl. Acad. Sci. 77: 4349-4353, Jul. 1980
Welch et al., Journal of Biological Chemistry 259: 4501-4513, Apr. 1984
Napier et al "Isoelectric Focussing of Human Urinary Erythropoietiu" IRCS Med. SCI4:437 (1976)
Andreux et al "Etude de l'erythropoietiue. . . " Annales Pharma. Francaises 31(1):29-36, (1973)